Searched for
A CHEM PHARMA
Q4 earnings roundup: Raymond Realty, MCX among 19 companies that delivered 100%+ growth in sales and PATA select group of 19 large-cap BSE-listed companies achieved triple-digit growth in both profit and revenue during Q4FY26, indicating stron...- Jio Financial, ITC Hotels and Manappuram Finance among stocks bought and sold by mutual funds in AprilMutual funds injected Rs 30,600 crore into Indian equities in April, with significant buying in ICICI Bank, SBI, and Sun Pharma. Key reduct...
- How Ashish Kacholia, Mukul Agrawal, Madhu Kela, Dolly Khanna reshuffled portfolios amid Iran war?Amid a sharp market sell-off triggered by Iran war tensions and rising oil prices, marquee investors like Ashish Kacholia, Mukul Agrawal, M...
- Mukul Agrawal picks 1.28% stake in this underperforming stock, drives 14% surgeAccording to the latest shareholding data for the quarter ending June 2025, the prominent investor acquired 3 lakh shares of the company, a...
- Sensex falls! But these stocks are up over 10% on BSEIn the Nifty 50 index, 23 stocks were trading in the green, while 27 stocks were trading in the red.
- Stock market update: Nifty Pharma index falls 0.91%The Nifty Pharma index closed 0.91 per cent down at 18525.75.
- Buy Tatva Chintan Pharma Chem, target price Rs 1590: Prabhudas LilladherTatva Chintan Pharma Chem Ltd., incorporated in the year 1996, is a Small Cap company (having a market cap of Rs 2851.61 Crore) operating i...
- International Chemical Investors Group buys Vasant ChemicalsWith state-of-the-art manufacturing facilities in Hyderabad (Jeedimetla) and Visakhapatnam (Atchutapuram), the Hyderabad-based Vasant Chemi...
- Buy Tatva Chintan Pharma Chem, target price Rs 2000: ICICI SecuritiesTatva Chintan Pharma Chem Ltd. key Products/Revenue Segments include Speciality Chemicals, Scrap and Export Incentives for the year ending ...
- PE firm Advent names its India API, CDMO platform as Cohance LifesciencesThe US-based PE firm which is betting on India pharma, said that it intends to add more assets in the future with the vision to become one ...
- Buy Tatva Chintan Pharma Chem, target price Rs 2730: ICICI SecuritiesTatva Chintan Pharma Chem Ltd., incorporated in the year 1996, is a Small Cap company (having a market cap of Rs 5047.54 Crore) operating i...
- Tatva Chintan Pharma sinks 10% as Q4 show disappointsEarlier this month, ICICI Securities said it has a buy call on Tatva Chintan Pharma Chem with a target price of Rs 3,000. Time period given...
- Buy Tatva Chintan Pharma Chem, target price Rs 3000: ICICI SecuritiesTatva Chintan Pharma Chem Ltd., incorporated in the year 1996, is a Small Cap company (having a market cap of Rs 5184.96 Crore) operating i...
- Buy Tatva Chintan Pharma Chem, target price Rs 3110: ICICI SecuritiesTatva Chintan Pharma Chem Ltd., incorporated in the year 1996, is a Small Cap company (having a market cap of Rs 5757.71 Crore) operating i...
- Buy Tatva Chintan Pharma Chem, target price Rs 2920: ICICI SecuritiesTatva Chintan Pharma Chem Ltd., incorporated in the year 1996, is a Small Cap company (having a market cap of Rs 5520.87 Crore) operating i...
- Tatva Chinta Pharma surges 11% as investors welcome industrial land buy in GujaratThe step, seen as an indicator of growth prospects by investors, send the company’s scrip shooting up to a high of Rs 2,599.90 on the Natio...
- Tatva Chintan Pharma Chem's Rs 500 cr IPO to open on July 16The offer size is Rs 500 crore, of which the company will issue fresh equity shares worth Rs 225 crore and offer for sale by promoters and ...
- Chemplast Sanmar, Tatva Chintan Pharma Chem get Sebi nod for IPOsChemplast Sanmar and Tatva Chintan Pharma Chem obtained Sebi's observations on July 2 and June 30 respectively, an update with Sebi showed ...
- PE fund Advent International buys controlling stake in API manufacturer RA Chem PharmaThe US private equity fund is understood to have pipped a rival offer from a consortium consisting another PE fund Carlyle Group and former...
- Indoco Remedies acquires La Nova ChemIndoco Remedies Ltd, a manufacturer and distributor of pharmaceutical products and services, on Tuesday said it has acquired a 100 per cent...
Load More
